Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Controlled Phase II Clinical Study to Evaluate Superiority of "InbioDerm+C" Autologous Stem Cell-Based Therapy Plus Advanced Healing Compared With Advanced Healing in Diabetic Foot Ulcer Patients

NCT05234086 is registered in ClinicalTrials.gov with Instituto para el Desarrollo Biotecnológico y la Innovación S.A. as lead sponsor.

NCT NCT05234086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05234086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Controlled Phase II Clinical Study to Evaluate Superiority of "InbioDerm+C" Autologous Stem Cell-Based Therapy Plus Advanced Healing Compared With Advanced Healing in Diabetic Foot Ulcer Patients
Lead sponsor
Instituto para el Desarrollo Biotecnológico y la Innovación S.A.
Phase
Phase 2
Overall status
Unknown status
Start date
January 2, 2020
Completion date
September 2, 2022
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer associated with type ii diabetes mellitus, wound heal